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Summary
b-catenin-mediated Wnt signaling may contribute to
the self-renewal of hematopoietic stemcells and prolif-
eration in some malignancies. We now show that ex-
pression of constitutively active b-catenin in normal
lymphoid or myeloid progenitors generated uncom-
mitted cells with multilineage differentiation potential.
Inappropriate gene expression occurred in cells des-
tined to produce either cell type and caused corre-
sponding changes in their characteristics. For exam-
ple, forced activation of b-catenin quickly increased
C/EBPawhile reducingEBFandPax-5 in lymphoidpro-
genitors that then generated myeloid cells. Inversely,
EBFdramatically increased in transducedmyeloidpro-
genitors and lymphocytes were produced. The results
indicate that ectopic activationofb-catenin destabilizes
lineage fate decisions and confers some, but not all,
stem cell properties on committed progenitors.
Introduction
Traditional models of blood cell formation depict the
production of lineage-committed progenitor cells from
multipotential hematopoietic stem cells (HSC), with pro-
gressive loss of differentiation options and self-renewal
activity (Orkin, 2000; Kincade et al., 2002). Hematopoi-
etic cell lineages are specified in a gradual process in-
volving intrinsic and extrinsic factors. Intermediate and
committed progenitors are characterized by patterns
of gene expression that are determined and maintained
by a combination of transcription factors and chroma-
tin-remodeling events. Substantial progress has been
made in learning how a small number of early-acting
transcription factors initiate the formation of lineage-
committed progenitors (Warren and Rothenberg, 2003).
Low-level expression of several of these occurs during
a ‘‘priming’’ phase (Miyamoto et al., 2002), and subse-
quent events depend on combinations and doses of
transcription factors in individual cells. In addition, cross
competition between transcription factors ensures that
differentiating cells lack properties of more than one lin-
eage.
Although progression in one of the major lineages is
thought to be unidirectional, there is growing evidence
for at least latent plasticity at early stages. For example,
lymphoid progenitors can convert to myeloid lineage
cells by ectopic activation of IL-2 or GM-CSF signaling
pathways (Kondo et al., 2000; Iwasaki-Arai et al., 2003)
*Correspondence: kincade@omrf.ouhsc.eduor erythrocyte/megakaryocytes by enforced expression
of GATA-1 (Iwasaki et al., 2003). Lymphoid lineage cell
lines switch to macrophages under certain conditions
(Boyd and Schrader, 1982; Klinken et al., 1988; Borzillo
et al., 1990). Furthermore, normal and malignant CD5+
B lymphocytes can develop macrophage-like character-
istics on fibroblasts (Borrello and Phipps, 1995). A re-
cent study showed that mature B lymphocytes can be
converted to macrophages under experimental circum-
stances (Xie et al., 2004). Inversely, there is one example
where macrophage tumor cells reacquired lymphoid
characteristics by manipulation of E2A (Kee and Murre,
1998). Finally, primitive progenitors converted to defini-
tive multipotent hematopoietic cells by ectopic expres-
sion of HoxB4 (Kyba et al., 2002) or Myb-Ets from the
E26 leukemia virus (McNagny and Graf, 2003).
Mechanisms for the earliest steps in normal lineage
commitment remain incompletely understood, but re-
cent studies indicate that the Wnt family of ligands,
receptors, and signal transmitting molecules may be in-
volved (Staal and Clevers, 2005). At least 19 Wnt pro-
teins bind to one of 10 Frizzled receptors, leading to in-
activation of the glycogen synthase kinase 3b (GSK3b).
In the absence of this signaling, GSK3b normally phos-
phorylates b-catenin, targeting it for destruction. Un-
phosphorylated b-catenin translocates to the nucleus,
where it modulates activity of the TCF/LEF family of
transcription factors and may induce chromatin remod-
eling for target gene expression through association
with Brg1, a component of SWI/SNF chromatin-remod-
eling complex (Nusse, 2005). This canonical pathway for
Wnt family signaling can be simulated by introduction of
a nondegradable form of b-catenin. Enforced expres-
sion of such a stable b-catenin in hematopoietic stem
cells of bcl-2 transgenic mice promoted stem cell self-
renewal (Reya et al., 2003). Wnt signaling is normally
reduced as stem cells convert to committed myeloid
progenitor cells (Reya et al., 2003). Also, purified
Wnt3a protein promotes HSC self-renewal in vitro (Wil-
lert et al., 2003). Conditional deletion of b-catenin from
adult hematopoietic stem cells in vivo did not cause
a self-renewal defect (Cobas et al., 2004). However, Pla-
koglobin (g-catenin) has overlapping functions and
could potentially substitute for b-catenin in hematopoi-
etic cells (Reya and Clevers, 2005) . In addition to HSC,
embryonic stem cells, epidermal stem cells, and epithe-
lial stem cells seem to be responsive to, or dependent
on, Wnt/b-catenin signaling to maintain them in an undif-
ferentiated, proliferating state (Willert et al., 2003; Kori-
nek et al., 1998; Sato et al., 2004; Gat et al., 1998; Zhu
and Watt, 1999). Furthermore, activation of b-catenin
in granulocyte-macrophage progenitors from the blast
crisis stage of chronic myelogenous leukemia (CML) ap-
pears to enhance their self-renewal and leukemic po-
tential (Jamieson et al., 2004). Such observations also
indicate that self-renewal programs may be reactivated
in committed hematopoietic progenitors as a result of
excess b-catenin stabilization.
Manipulation of self-renewal properties represents
a major goal of stem cell studies, and it was important
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600Figure 1. Expression of Constitutive Stable b-Catenin in Lymphoid Progenitors Confers Myeloid Lineage Differentiation Potential
(A) Transduced GFP+ lymphoid progenitors with either control vector or stable b-catenin were sorted and cocultured for 14 days on OP9 stromal
cells with SCF, FL, and IL-7. Flow cytometry was then used to detect various myeloid and B lineage lymphoid cells.
(B) Mac-1+ cells were sorted after OP9 coculture, and a May-Grunwald-Geimsa-stained cytospin preparation is shown.
(C) After the first 7 days, and at 7 day intervals, cells were harvested and counted, and then 10,000 were replated on fresh OP9 stromal cells.
(D) CD11b/Mac-1+ cells with or without the CD11c dendritic marker were recovered from 14 day cultures and purified genomic DNA was eval-
uated for IgH gene rearrangements. Freshly sorted CD19
+ cells and Lin2c-KitLoSca-1LoIL-7Ra+ lymphoid progenitors from bone marrow were
used as positive controls and compared to CD11b/Mac-1+ cells generated from HSC fraction in culture.to learn the consequences of inappropriate stimulation
of the Wnt/b-catenin pathway in normal hematopoietic
cells. We now show that enforced expression of a con-
stitutively active form of b-catenin confers multilineage
differentiation potential on lymphoid and myeloid pro-
genitors through inappropriate gene expression. Activa-
tion of b-catenin signaling in committed progenitors may
reactivate part of the stem cell program, leading to line-
age infidelity/instability.
Results
Expression of Active b-Catenin in Lymphoid
Progenitors Expands Cells with Multilineage
Differentiation Potential
In a companion study, introduction of stable b-catenin
allowed long-term growth of primitive hematopoietic
cells without loss of differentiation potential (Y.B. et al.,
submitted). We have now investigated the influence
of this treatment on highly enriched Lin2IL-7Ra+
c-KitloSca-1lo lymphoid progenitors. Cells transduced
with control vector or stable b-catenin were preparedand placed in OP9 stromal cell cocultures along with
SCF, FL, and IL-7. Under these conditions, lymphoid
progenitors receiving the control vector generated
almost pure populations of CD19+ lymphocytes (Fig-
ure 1A), along with very small numbers of CD11b/
Mac-1+CD11c+ dendritic cells (data not shown). In con-
trast, introduction of stable b-catenin caused substan-
tial increases in dendritic cells and myeloid cells bearing
either Gr-1 or F4/80 (Figure 1A). Examination of cytocen-
trifuge slides revealed cells with dendritic and granulo-
cyte/monocyte morphologies (Figure 1B). Absolute
numbers of CD19+ lymphocytes were reduced by 15.6-
fold at 2 weeks and b-catenin-stimulated expansion of
total nucleated cells beyond this time (Figure 1C).
Cells with a lymphoid ancestry would be expected to
have undergone immunoglobulin gene rearrangements,
and this point was investigated with sorted cells ex-
pressing myeloid (CD11b/Mac-1+CD11c2) and dendritic
(CD11b/Mac-1+CD11c+) markers. Ig DH-JH rearrange-
ment products were found in lymphoid progenitors that
had converted to both of these cell types after transduc-
tion with b-catenin (Figure 1D). None were found when
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601Figure 2. Expression of Constitutive Stable b-Catenin in Lymphoid Progenitors Confers Multilineage Differentiation Potential
(A) CD192Mac-12 cells in 14 day primary cultures initiated with stable b-catenin were sorted and tested for differentiation potential. Cells sub-
cultured onto OP9 with FL and IL-7 generated both CD19+ B and CD11b/Mac-1+ lineage cells (left two panels). CD33+ T lineage cells emerged
within 3 weeks onto OP9 stromal cells transduced with the Delta-like 1 Notch ligand (OP9-DL1) (right two panels).
(B) Lymphoid progenitors transduced with control vector or b-catenin were cocultured on OP9 stromal cells in the presence of SCF, FL, and IL-7.
After 14 days, 13 106 cells were injected into sublethally irradiated NOD/SCID mice. After 5 weeks, cells were isolated from spleens before anal-
ysis by flow cytometry.a nontransduced stem cell-rich fraction was used to gen-
erate CD11b/Mac-1+ cells in culture (Figure 1D).
OP9 stromal cell cocultures of b-catenin-transduced
lymphoid progenitors contained CD192 CD11b/Mac-12
cells with many primitive characteristics. That is, they
were c-kit+Sca-1Lo/2CD43+AA4.1+Ter-1192CD32DX-
52NK1.12CD11c2Gr-12 and only expressed the
CD45R/B220+ marker that is frequently used to subdi-
vide B lineage lymphocytes (data not shown). We sorted
and subcultured these CD192CD11b/Mac-12 cells on
OP9 stromal cells with FL and IL-7 to assess their differ-
entiation potential. SCF was omitted at this stage be-
cause preliminary experiments demonstrated that this
cytokine promoted retention of primitive characteristics.
After 10 days, CD19+ and CD11b/Mac-1+ cells were
again present (Figure 2A). Small numbers of CD3+ T line-
age cells were generated when the cells were transferred
to Delta-like 1 transduced OP9 (OP9-DL1) stromal cells
(Schmitt and Zu´n˜iga-Pflu¨cker, 2002) and TCR g/d+ lym-
phocytes predominated over TCR a/b+ cells at 3 weeks
of culture (data not shown).
Bone marrow cells cultured for 2 weeks were trans-
ferred to sublethally irradiated NOD/SCID mice as an ad-
ditional test of differentiation potential. No donor-type
CD45.2-marked cells were found in recipients of cul-
tures established from control vector-transduced cells
(Figure 2B). In contrast, CD19+CD45R/B220+ lympho-
cytes were present in spleens of mice 5 weeks after
receiving stable b-catenin-transduced cells. Small num-
bers of CD11b/Mac-1+ myeloid cells were also present.
Donor type T cells were not observed in the spleen or
thymus (Figure 2B and data not shown), even though
the 5 week interval is sufficient for T lymphopoiesis
from stem cells (Spangrude and Scollay, 1990).These results demonstrate that lymphoid-committed
progenitors can be expanded in culture for at least
4 weeks under the influence of ectopic b-catenin, but
became less restricted with respect to fate. Primitive
CD192CD11b/Mac-12 cells recovered from these cul-
tures had myeloid, as well as B and T lineage, differenti-
ation potential.
Ectopic Activation of b-Catenin in Myeloid
Progenitors Confers Multilineage
Differentiation Potential
A reporter system was previously used to determine that
b-catenin activity is detectable in Lin2c-KithiSca-1+HSC,
but not in Lin2c-KithiSca-12 progenitors (Reya et al.,
2003). Downregulation of Wnt pathway signaling might
accompany or be a requirement for lineage progression.
Therefore, we investigated whether ectopic b-catenin
would influence self-renewal and lympho/myeloid
development in myeloid progenitors. Purified Lin2IL-
7Ra2c-KithiSca12myeloid progenitors were transduced
with stable b-catenin or control vector before culturing
on OP9 stromal cells with SCF, FL, and IL-7. After 10
days, cells expressing control vector generated only
CD11b/Mac-1+ myeloid lineage cells. Artificial expres-
sion of stable b-catenin allowed myeloid progenitors to
generate not only myeloid cells but also CD19+ B lineage
cells under these conditions (Figure 3A). In addition, the
b-catenin-transduced cells had a growth advantage
over the control vector-expressing cells (Figure 3B).
To determine whether differentiation was an ongoing
process, we purified the predominant CD192Mac-12
fraction from primary cultures of b-catenin-transduced
myeloid progenitors. Flow cytometry revealed that the
sorted cells were Lin2c-kit+Sca-1Lo/2CD45R/B220+
Immunity
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(A) GFP+ myeloid progenitors transduced with control vector or stable b-catenin were sorted and cocultured on OP9 stromal cells in the presence
of SCF, FL, and IL-7. B (CD19) or myeloid (Mac-1) lineage differentiation was assessed by flow cytometry at 10 days. May-Grunwald-Geimsa
staining of sorted CD19+ cells is shown.
(B) After the first 10 days, and at 10 day intervals, cells were harvested and counted, and then 10,000 were replated on fresh OP9 stromal cells.
Duplicate cultures were prepared in four independent experiments and the results were pooled for analysis. Error bars represent standard de-
viations (SD) of the mean.
(C) CD192Mac-12 cells derived from stable b-catenin expressing myeloid progenitors were sorted and allowed to differentiate to CD19+ and
Mac-1+ cells on OP9 stromal cells in the presence of FL and IL-7 during an additional 10 days (left). Sorted CD192Mac-12 cells also gave rise
to abT and gdT cells when held for 3 weeks on OP9-DL1 stromal cells in the presence of FL and IL-7 (right three panels).
(D) Myeloid progenitors transduced with control vector or b-catenin were cocultured on OP9 stromal cells for 10 days in the presence of SCF, FL,
and IL-7 and 13 106 cells were injected into sublethally irradiated NOD/SCID mice. After 5 weeks, cells were isolated from spleen and analyzed
by flow cytometry.CD43+AA4.1+Ter-1192CD32DX-52NK1.12CD11c2Gr-12
at that time (data not shown). Ten days after subculture
on OP9 stromal cells with only FL and IL-7, B lineage
lymphoid and myeloid cells were again made under
these conditions while subculture on OP9-DL1 cells
supported impressive generation of T lineage lympho-
cytes (Figure 3C). Freshly isolated myeloid progenitors
did not generate T lineage cells on OP9-DL1 under these
conditions (data not shown). Unlike the situation with
transduced lymphoid progenitors, TCRa/b+ cells predom-
inated over lymphocytes with g/d receptors. As recently
found in another study with freshly harvested hemato-
poietic cells (Huang et al., 2005), Delta-like 1 Notch
ligand suppressed myelopoiesis as well as B lympho-
poiesis.
Myeloid progenitors were then transduced with con-
stitutively active b-catenin and expanded on OP9 stro-
mal cells with cytokines for 10 days before transfer to
sublethally irradiated NOD/SCID mice. As was the case
with transduced lymphoid progenitors, donor type B lin-
eage lymphocytes and myeloid cells, but not T cells,were recovered from recipient spleens (Figure 3D) or thy-
mus (data not shown).
These observations suggested that committed my-
eloid progenitors might become lineage unstable
as they are expanded under the influence of stable
b-catenin. The point was further investigated with pro-
genitors subdivided according to other parameters
(Akashi et al., 2000). A Lin2c-KitHiSca-12FcgRLoCD342
subset previously designated megakaryocyte/erythro-
cyte progenitor (MEP) did not survive transduction
with either the control or b-catenin-containing vectors.
However, Lin2c-KitHiSca-12FcgRLoCD34+ common my-
eloid progenitors (CMP) thrived after this treatment and
generated both lymphoid and myeloid progeny in 10 day
stromal cell cocultures (Figure 4). In contrast, a very sim-
ilar Lin2c-KitHiSca-12FcgRHiCD34+ granulocyte/macro-
phage progenitor (GMP) subset did not expand as well
and appeared to be more myeloid lineage restricted.
Both of these subsets produced many CD192CD11b/
Mac-12 cells in response to b-catenin, while few grew
from cells given the control vector.
Lineage Infidelity Caused by b-Catenin
603Figure 4. One Subset of Myeloid Progenitors
Efficiently Gives Rise to B Lineage Cells after
b-Catenin Activation
Lin2c-KitHiSca-12CD34+FcgRII/IIILoCMP and
Lin2c-KitHiSca-12CD34+FcgRII/IIIHiGMP were
sorted and transduced with either control
vector or stable b-catenin. GFP+ cells were
then isolated and cocultured on OP9 stromal
cells in the presence of SCF, FL, and IL-7 for
10 days. The bar graphs indicate yields, i.e.,
numbers of CD19+ B, CD11b/Mac-1+ myeloid
lineage, or CD192CD11b/Mac-12 undifferen-
tiated cells recovered per input cell. Error
bars represent SD of the mean for cell num-
bers from three independent experiments.We conclude that stable b-catenin permits substantial
growth of at least two subsets of largely restricted mye-
loid progenitors and causes one of them to become lin-
eage unstable.
Stable b-Catenin Disrupts Lineage Restriction
in Lymphoid and Myeloid Progenitors
Clonal studies were then conducted to learn if active
b-catenin selects for rare contaminating cells or confers
lineage instability to cells that should have restricted
fates. We sorted single cells transduced with control
or active b-catenin into 96-well plates containing OP9
stromal cells, SCF, FL, and IL7. After 12 days, flow cy-
tometry was used to discern four distinct phenotypes
(Figure 5). Some cultures maintained primitive proper-
ties and expressed neither CD19 nor CD11b/Mac-1.
Other cultures contained both B and myeloid lineage
cells (B+M), while still others had restricted B or myeloid
lineage cells (B or M). Although b-catenin expression did
not substantially affect the plating efficiency of HSC-
enriched Lin2c-KitHiSca-1+IL-7Ra2 marrow cells, num-
bers of clones with primitive cells were increased. Out-
growth of bipotent, B/myeloid cells was also increased,
suggesting that b-catenin enhanced uncommitted cells
rather than committed B or myeloid progenitors.
Lin2c-KitLoSca-1LoIL-7Ra+ lymphoid progenitors
transduced with the control vector exclusively gave
rise to CD19+ B cells. In striking contrast, lymphoid cells
receiving active b-catenin generated all possible combi-nations of progeny. Similarly, cells that were largely re-
stricted to a myeloid fate generated mixed populations
of lymphoid and myeloid cells when transduced with
stable b-catenin.
We conclude that restricted progenitors become
unstable under the influence of constitutively active
b-catenin, generating primitive cells as well as those
corresponding to other lineages.
Active b-Catenin Changes Gene Expression Patterns
in Committed Progenitors
The above findings suggest that active b-catenin can
destabilize fate determination in committed progenitor
cells, and we used semiquantitative RT-PCR to evaluate
the expression of selected genes 48 hr after control vec-
tor or stable b-catenin transduction. Of particular inter-
est were transcription factors known to be associated
with lineage choice selection and self-renewal in primi-
tive cells. Three substantial changes were found in lym-
phoid progenitors. EBF levels declined approximately
70%, while Pax-5 was extinguished and C/EBPa tran-
scripts increased approximately 12-fold (Figure 6A).
A dramatic induction in EBF was the only significant
change found in myeloid progenitors transduced with
b-catenin (Figure 6B). We were surprised not to find
changes in HoxB4, Notch-1, or PU.1. A larger screen
for gene expression was then made with the same sam-
ples (see Figure S1 in the Supplemental Data available
with this article online). Interpretation of some patternsFigure 5. Altered Lineage Fates of Lymphoid and Myeloid Progenitors Resulting from Activation of b-Catenin
Single sorted GFP+ cells from a HSC-enriched fraction, lymphoid progenitors, or myeloid progenitors transduced with control vector or stable
b-catenin were cultured on OP9 stromal cells in 96-well plates for 12 days in the presence of SCF, FL, and IL-7. Positive readout wells (more than
40 cells) were determined by microscopic observation and phenotypes were determined by flow cytometry (representative examples shown on
top row). The frequencies of wells with each of these differentiation patterns are shown along with total numbers of clones observed.
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Progenitors of the indicated types were transduced with control vector or stable b-catenin for 48 hr before sorting for GFP+ cells. Freshly isolated
lymphoid progenitors and myeloid progenitors were used as controls. Semiquantitative RT-PCR was carried out to amplify transcripts for the
indicated genes in each population. The bar graphs represent the results of [a-32P]dCTP incorporation on the linear parts of PCR amplification
curves normalized relative to b-actin control values as detailed in Experimental Procedures.is complicated by the fact that control transduced cells
differed from freshly isolated progenitors. However, it is
interesting that b-catenin may prolong expression of
Gfi-1, Bmi-1, and Aiolos in cultured lymphoid cells, as
well as Bmi-1 and the Id-3 transcriptional repressor in my-
eloid progenitors. We conclude that ectopic b-catenin
results in inappropriate expression of several genes
known to control differentiation patterns.
Discussion
Defining properties of committed progenitors include fi-
nite renewal capacity and some loss of differentiation
options. The transition of self-renewing, pluripotent
stem cells to myeloid progenitors is accompanied by
downregulation of Wnt signaling (Reya et al., 2003),
and we have now explored the outcome of reactivated
b-catenin in that cell type. In parallel, stable b-catenin
was expressed in lymphoid progenitors to determine if
this mediator of Wnt signaling influenced their proper-
ties. The treatment gave a growth advantage to and re-
vealed latent differentiation potential in both cell types.
While b-catenin altered expression of some early acting
transcription factors and restored multiple differentia-
tion options, individual cells that resulted did not have
markers associated with two lineages. These findings
help to define the activities of one member of a complex
signaling pathway and suggest how it might contribute
to hematopoietic malignancies.
There have been many reports where lymphoid cells
acquired myeloid characteristics under experimental
circumstances (Boyd and Schrader, 1982; Klinken
et al., 1988; Borzillo et al., 1990). In one recent example,
sIgM+ B cells were converted to macrophages by strong
overexpression of C/EBPa or C/EBPb (Xie et al., 2004).That would appear to be a clear case of lineage conver-
sion, since single cells with lymphoid and myeloid char-
acteristics were found during the transition. The same
was true with cloned tumor cell lines that lost differenti-
ated properties and acquired many new ones (Graf,
2002). Other investigators have shown that progenitors
largely committed to a lymphoid fate could be redi-
rected to become granulocytes and macrophages by
artificial expression of receptors for growth and differen-
tiation factors (Kondo et al., 2000; Iwasaki-Arai et al.,
2003). In addition, lymphoid progenitors became mega-
karyocytes and erythroid cells as a result of GATA-1
overexpression (Iwasaki et al., 2003). These studies
demonstrate that progenitors retain latent differentia-
tion potential and that characteristics of fully mature
lymphocytes are maintained by a few critical transcrip-
tion factors. Those regulators both maintain expression
of lymphoid genes and repress those corresponding to
alternate fates. The many instances of lymphoid to my-
eloid conversion could also be interpreted in terms of
the latter representing a default state.
Given this extensive literature, it was not surprising
that stable b-catenin conferred myeloid potential on
lymphoid progenitors. While the transduction also
gave cells a growth advantage, our clonal analyses ar-
gue against the possibility that rare multipotential cells
contaminated the highly enriched suspensions and sim-
ply expanded with time. Furthermore, the presence of Ig
DH-JH rearrangement products in dendritic and myeloid
cells provides strong evidence that they arose from
progenitors that were originally lymphoid committed.
Flow cytometry revealed that the transduced cells
were Lin2c-kit+Sca-1Lo/2CD45R/B220+CD43+AA4.1+
10 days after transduction and culture initiation.
CD45R/B220 is not a B lineage-restricted marker, and
individual cells with combined lymphoid and myeloid
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This suggests that active b-catenin did not cause gener-
alized gene expression, but rather permitted latent dif-
ferentiation options to be exercised.
EBF is essential for initiating and maintaining B lym-
phopoiesis (Lin and Grosschedl, 1995; Maves and Schu-
biger, 2003; Singh et al., 2005), so rapid downregulation
of this transcription factor is consistent with at least
some cells in the population becoming myeloid compe-
tent. More dramatic was the extinction of Pax-5, a factor
required for intermediate and late stages of B lympho-
cyte formation (Nutt et al., 1999; Rolink et al., 1999).
Note that the most primitive, early lymphoid progenitors
within normal bone marrow are Pax-52 (Igarashi et al.,
2002). C/EBPa levels increased under the influence of
b-catenin and C/EBPa is reported to suppress Pax-5
activity (Xie et al., 2004).
In contrast to the lymphoid to myeloid conversion,
there are few examples where nonlymphoid cells or
committed progenitors were spontaneously or experi-
mentally turned into lymphocytes. Kee and Murre ma-
nipulated a macrophage-like variant of the 70Z/3 pre-B
lymphoma (Kee and Murre, 1998). They found that lym-
phoid characteristics were dramatically restored by ex-
pression of the E2A transcription factor. Rare, CD45R/
B2202 cells in bone marrow that express CD19 retain
some potential to generate macrophages and B lineage
lymphocytes (Montecino-Rodriguez et al., 2001). While
this shows that display of CD19 is not necessarily a
definitive lymphoid characteristic, the findings do not
prove that committed lymphoid or myeloid progenitors
spontaneously undergo lineage conversion. It is clear
in our study that at least two major subsets of T cells
(a/b and g/d TCR+ cells), as well as CD19+ B lineage lym-
phocytes, were generated from myeloid progenitors in
response to stable b-catenin. The Lin2c-KitHiSca-
12FcgRLoCD34+ population referred to as common my-
eloid progenitors was particularly prone to generating
lymphocytes under these conditions. This potential
was present to a lower degree in a companion Lin2c-
KitHiSca-12FcgRHiCD34+ granulocyte/macrophage pro-
genitor subset.
It is to be expected that lymphoid-related genes
would be expressed in cultures that produce lympho-
cytes, but EBF was detectable in myeloid progenitors
within 48 hr of stable b-catenin introduction. This may
represent a key event because Pax-5 transcripts were
not found and myeloid-permissive C/EBPa was not sup-
pressed at that time. It is noteworthy that HOXB4 and
Notch 1 levels were unchanged in either cell type, al-
though this has been shown in another context to be
a target of Wnt pathway signaling (Reya et al., 2003).
Also, no significant changes were found in PU.1, al-
though doses of this transcription factor are key in lym-
phoid versus myeloid differentiation decisions (DeKoter
and Singh, 2000). A very recent study demonstrated that
while critical amounts of PU.1 may be needed to pro-
duce lymphoid progenitors, it is not required to sustain
that lineage (Iwasaki et al., 2005). Transcripts for
GATA-3, Aiolos, Gfi-1, Bmi-1, and Id-3 were lower in
cells that had been transduced with control vector
than in the freshly isolated progenitors, but were normal
to high in b-catenin-expressing progenitors. The Bmi-1
and Gfi-1 members of the polycomb group of genesare thought to have key roles retaining stem cell proper-
ties (Cellot and Sauvageau, 2005; Iwama et al., 2004),
and it will be interesting to learn if they are targets of
Wnt pathway signaling in other cell types.
These observations should be considered in context
with a parallel study, where we introduced stable
b-catenin to more primitive cells (Y.B. et al., submitted).
In that case, long-term cultured, multipotential cells
could be established and maintained in the presence
of just two cytokines, SCF and IL-6. Of particular note,
the cells were not obviously transformed after many
passages and retained the ability to differentiate in re-
sponse to normal environmental cues. While this might
be interpreted in terms of retention of stem cell proper-
ties, the present findings suggest that it may also be
possible to induce some stem cell characteristics in par-
tially committed progenitors by ectopic expression of
stable b-catenin.
In that sense, our results could represent an example
of retrodifferentiation of hematopoietic cells (Graf,
2002). However, b-catenin-transduced progenitors did
not reconstitute T cells when transplanted to immuno-
deficient mice. This is despite the fact that the same
manipulated progenitors generated T lineage cells in
the OP9-DL1 coculture system, and the b-catenin-
dependent TCF/LEF genes are important for T cell for-
mation (Reya and Clevers, 2005; Verbeek et al., 1995).
We had the same experience with b-catenin-transduced
HSC, and it is possible the cultured cells are unable to
home to the recipient thymuses (Y.B. et al., submitted).
The findings are compatible with another study, where
thymuses with experimentally elevated b-catenin were
only 10% normal size due to reduced proliferation and
increased thymocyte death (Gounari et al., 2001). This
situation does contrast with long-term cultures pre-
pared from Pax-5 or E2A targeted cells (Nutt et al.,
1999; Rolink et al., 1999; Ikawa et al., 2004). Thus,
b-catenin is not sufficient for committed cells to reaquire
all stem cell properties.
Two other reports demonstrated the conversion of
progenitors to multipotential cells. One showed that
HoxB4 overexpression induced the expansion of defini-
tive HSC and conferred long-term, multilineage potential
to primitive hematopoietic cells derived from yolk sac
(Kyba et al., 2002). The other study demonstrated that
Myb-Ets oncoprotein of E26 leukemia virus converted
primitive erythroid cells into proliferating definitive multi-
potent cells (McNagny and Graf, 2003). Although our
study did not detect any difference in HoxB4 expression
levels, it will be interesting to determine whether stable
b-catenin expression induces Myb-Ets target genes.
Recently, a somewhat different concept has emerged
from fate switch studies in Drosophila. Imaginal disc
cells are rigidly determined to form specific structures
late in larval development. However, they can switch
fates during regenerative cell divisions (Maves and
Schubiger, 2003). In addition, ectopic expression of
the Wingless (Wg) member of the Wnt family can induce
transdetermination with unique cell cycle state and cell
size, but not retrodifferentiation (Sustar and Schubiger,
2005). This work, together with our findings, suggests
that Wnt/Wg signaling allows cells to acquire an appar-
ently novel multipotential state without conversion to
true stem cells.
Immunity
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physiological conditions, they should be relevant to ma-
lignancy, inflammation, or pathogenic infections (Reya
and Clevers, 2005). Disregulation of the Wnt/b-catenin
pathway may be particularly important in leukemia (Ser-
insoz et al., 2004; Chung et al., 2002; Jamieson et al.,
2004; Lu et al., 2004; Shackelford et al., 2003). Although
we saw no indication that stable b-catenin was sufficient
for leukemic transformation of progenitor cells, it will be
important to learn whether the Wnt signaling pathway
contributes to any of the malignant examples of lineage
instability. For example, myeloid leukemia can undergo
blast crisis with lymphoid characteristics including rear-
rangement of TCR or Ig genes (Cheng et al., 1986;
Boggs, 1974; Stass et al., 1984). Conversely, switching
of acute lymphoblastic leukemia cells to myeloid line-
ages has also been reported (Hershfield et al., 1984;
Stass et al., 1984; Nosaka et al., 1988). This behavior
has been referred to as ‘‘lineage infidelity’’ (Smith
et al., 1983; Schmidt and Przybylski, 2001).
Several reports suggest that b-catenin may be in-
volved in chromatin remodeling. For example, b-catenin
physically interacts with CBP/p300, which is known to
function as a transcriptional coactivator (Takemaru
and Moon, 2000; Hecht et al., 2000). CBP/p300 has in-
trinsic histone acetyltransferase (HAT) activities that al-
ter chromatin structure by covalent modification of nu-
cleosomal histones, which in turn play a major role in
regulation of gene expression (Ogryzko et al., 1996). Fur-
thermore, Brg1 has been identified as a binding partner
of b-catenin, a component of the SWI/SNF chromatin-
remodeling complex that can induce the expression of
target genes by facilitating DNA accessibility (Barker
et al., 2001). This complex has been shown to regulate
T lymphocyte development in the thymus (Chi et al.,
2002, 2003; Gebuhr et al., 2003). More recently, it has
been shown that Pygopus associates with b-catenin
through the Lgs/Bcl-9 adaptor protein (Kramps et al.,
2002). The complex of Pygopus-Lgs/Bcl-9 allows
b-catenin to localize to the nucleus, which may be re-
quired for maximum activation of b-catenin- and LEF/
TCF-dependent promoters/genes (Thompson et al.,
2002; Parker et al., 2002; Belenkaya et al., 2002). Inter-
estingly, the Pygopus protein contains a PHD domain,
often found in chromatin-remodeling factors that are
thought to alter chromatin structure and thereby allow
activation or repression of specific genes (Aasland
et al., 1995). This body of work suggests mechanisms
through which enforced b-catenin activation could dis-
rupt chromatin status and cause instability of gene
expression.
Our findings demonstrate that manipulation of
b-catenin can directly influence the survival and differen-
tiation of normal hematopoietic progenitors. This infor-
mation is not necessarily relevant to physiologic pro-
cesses, but could be important as attempts are made
to exploit the Wnt signaling pathway for tissue regenera-
tion (Moon et al., 2004).
Experimental Procedures
Mice and Cell Lines
C57BL/6 (CD45.2 alloantigen positive) and NOD/SCID mice were
purchased from the Jackson Labs (Bar Harbor, ME) and maintainedin our laboratory animal facility. The murine OP9 and OP9-DL1 stro-
mal cell lines were obtained from Dr. Juan Carlos Zu´n˜iga-Pflu¨cker at
the University of Toronto and maintained in a-MEM supplemented
with 20% FCS.
Antibodies
Anti-CD45RA (14.8) mAb, developed in our laboratory, and the anti-
CD11b/Mac-1 (M1/70) mAb were used as culture supernatants of
the respective hybridomas. Purified anti-erythroid (Ter-119) and
anti-Gr-1 (Ly-6G; RB6-8C5) antibodies, FITC-conjugated anti-Ter-
119, anti-Gr-1, anti-CD11b/Mac-1, anti-CD45R/B220 (RA3/6B2),
anti-CD19 (ID3), anti-CD2 (LFA-2), anti-CD3 (145-2C11), anti-CD34
(RAM34), and anti-CD8a (53-6.7) antibodies, PE-conjugated anti-
IL-7Ra chain (SB/199), anti-Sca-1 (Ly6A/E; E13-161.7), anti-FcgRII/III
(2.4G2), anti-CD19, anti-Gr-1, anti-CD11c (HL3), anti-CD45R/B220
(RA3/6B2), anti-pan NK cell (DX5/CD49), anti-TCRb (H57-597),
anti-TCRgd (GL3), anti-CD43 (S7), anti-C1qRp (AA4.1), anti-CD135
(Flk2/Flt3, Ly-72), anti-CD4 (L3T4), biotin-conjugated anti-Sca-1,
anti-VCAM-1 (429 MVCAM.A), APC-conjugated anti-c-Kit (2B8),
anti-CD11b/Mac-1 (M1/70), anti-CD3 (145-2C11), and anti-CD8a
(53-6.7) mAb were all purchased from BD PharMingen. APC-conjugated
anti-F4/80 was purchased from eBioscience. A phycoerythrin-Texas
red tandem-conjugated streptavidin (PE-Texas red-streptavidin)
was purchased from Caltag.
Cell Sorting
Bone marrow cells were harvested and enriched for lineage negative
cells by incubation with antibodies to Gr-1 and CD11b/Mac-1 for
myeloid cells, CD45R/B220 for B lineage cells, and Ter-119 for ery-
throid cells, followed by negative selection via the MACS cell sepa-
ration system (Miltenyi Biotec). These partially lineage-depleted
cells were further stained with FITC-labeled lineage markers Gr-1,
CD11b/Mac-1, CD2, CD19, CD3, CD8a, Ter-119, CD45R/B220 and
PE-anti-IL-7Ra chain, APC-anti-c-kit (2B8), and biotin-anti-Sca-1
antibodies followed by streptavidin PE-Texas red. Lymphoid pro-
genitors and myeloid progenitors were sorted as Lin2IL-7Ra+c-
KitLoSca1Lo and Lin2IL-7Ra2c-KitHiSca12, respectively. To further
subdivide myeloid progenitors, the sorted Lin2IL-7Ra2Sca12c-KitHi
population was restained with FITC-anti-CD34 and PE-anti-FcgRII/
III antibodies and sorted as Lin2IL-7Ra2Sca12c-KitHiCD34+FcgRII/
IIILo (CMP), Lin2IL-7Ra2Sca12c-KitHiCD34+FcgRII/IIIHi (GMP), and
Lin2IL-7Ra2Sca12c-KitHiCD342FcgRII/IIILo (MEP) (Akashi et al.,
2000). All sorts were performed with either a MoFlo (Cytomation)
or FacsAria (Becton Dickinson).
Retrovirus Production and Infection
A retroviral vector containing a cDNA encoding HA-tagged stable
b-catenin has been described in detail elsewhere (Y.B. et al., submit-
ted). A cDNA encoding HA-tagged stable b-catenin with substitute
mutations of S33A, S37A, T41A, and S45A (a gift from Dr. Shin-ichi
Hayashi) was cloned into the LZRS-IRES-GFP retroviral vector
(a gift from Dr. Hergen Spits). The resulting vector and a control lack-
ing b-catenin were transfected into EcoPack2 (BD Biosciences)
by FuGENE6 (Roche), and transfected cells were selected with
2 mg/ml puromycin (Sigma). Supernatants were harvested 24 hr after
changing media and immediately used for infections.
For infection of progenitors, sorted cells were deposited into
single wells of 24-well plates at 1 3 104 to 5 3 105 cells per well in
X-VIVO15 medium (Bio Whittaker) containing 1% detoxified bovine
serum albumin (Stem Cell Technologies), 2 mM L-glutamine, 5 3
1025 M 2-mercaptoethanol, 100 U/ml penicillin, and 100 mg/ml strep-
tomycin plus 20 ng/ml recombinant mouse stem cell factor (SCF),
100 ng/ml Flk2/Flt3 ligand (FL), and 1 ng/ml IL-7 for lymphoid pro-
genitors or 20 ng/ml SCF for myeloid progenitors. Equal volumes
of virus supernatant containing growth factor and 8 mg/ml polybrene
(Sigma) were added. Spin infections were then conducted for 2 hr at
2000 rpm in a centrifuge at 32ºC and the plates were incubated at
37ºC for 5 hr. Culture media was replaced with fresh media contain-
ing fresh virus supernatant, growth factor, and polybrene, and then
spin infection was repeated as before. After infection, cells were in-
cubated at 37ºC overnight. Culture media was replaced the following
day with fresh media containing growth factors and incubated for an
additional 24 hr. For infection of the HSC-enriched fraction, sorted
cells (Lin2c-kithiSca-1+IL-7Ra2) were prestimulated in X-VIVO15
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5 3 1025 M 2-mercaptoethanol, 100 U/ml penicillin, and 100 mg/ml
streptomycin in the presence of 20 ng/ml SCF, 100 ng/ml FL, and
20 ng/ml thrombopoietin (TPO) for 16–18 hr. Spin infection was
then conducted with the same cytokines. After infection, GFP-
positive cells were purified by MoFlo. All cytokines were purchased
from R&D Systems.
Culture Assays and Flow Cytometry
To evaluate B and myeloid lineage cell differentiation, single cells or
1000 cells of each sorted fraction were cocultured with OP9 cells in
single wells of 96-well or 24-well plates in the presence of SCF
(20 ng/ml), FL (100 ng/ml), and IL-7 (1 ng/ml) for the indicated peri-
ods. To evaluate T lineage cell differentiation potential, 10,000
CD192Mac-12 cells were recovered and sorted from primary OP9
cultures and then subcultured with OP9-DL1 stromal cells in the
presence of FL (100 ng/ml) and IL-7 (1 ng/ml) for 3 weeks. At the
end of culture, cells were counted excluding stromal cells and
then subjected to flow cytometry. A biotinylated anti-VCAM-1 mAb
was used to exclude potential contamination of VCAM-1+ stromal
cells in the analyzed populations and 7AAD was used to exclude
dead cells. Flow cytometry was performed on a FACSCalibur, and
the data were analyzed with Flowjo software (Treestar).
Transplantation of Cultured Hematopoietic Cells
The sorted progenitors were transduced with control vector or sta-
ble b-catenin before being cultured on OP9 stromal cells in the pres-
ence of SCF, FL, and IL-7. Then, 1 3 106 cultured cells were trans-
ferred intravenously into sublethally irradiated (200 rad) NOD/SCID
mice. Spleens were harvested from these mice and analyzed by
flow cytometry 5 weeks postinjection. CD45.2 and GFP were used
to distinguish host cells from donor cells.
Ig Gene Rearrangement Assay
Genomic DNA was isolated from sorted cells with a DNeasy Tissue
Kit (QIAGEN). PCR reactions were conducted as described else-
where (Igarashi et al., 2002). The primers used were DHL(50) and
J3(30) to detect DH-JH rearrangement and a-actin as described (Igar-
ashi et al., 2002). PCR products were electrophoresed through 1.4%
agarose gels in TAE buffer and products were visualized by ethidium
bromide staining.
Semiquantitative RT-PCR Analysis of Gene Expression
The mRNAs were isolated from sorted cells by MicroPoly(A) Pure
(Ambion). cDNA was prepared from DNase I-treated mRNA by
oligo-dT and Moloney murine leukemia virus reverse transcriptase
(Invitrogen). PCR reactions were conducted in buffer containing
200 mM dATP, dGTP, dTTP, 100 mM dCTP, and 0.5 mCi [a-32P]dCTP.
Aliquots were removed at cycle 25, 28, and 31 for b-actin and cycles
32, 35, and 38 for all others to insure that PCR remained within the
exponential range of amplifications. 5 ml aliquots were denatured
in a formamide-loading buffer and applied to a 6% polyacrylamide
gel containing 7 M urea. Incorporation of [a-32P]dCTP into PCR
product bands was quantified by PhosphoImager (Molecular Dy-
namics). Primer sequences and amplification conditions are avail-
able from the authors on request.
Supplemental Data
Supplemental Data include one figure and can be found with this
article online at http://www.immunity.com/cgi/content/full/23/6/
599/DC1/.
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